Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 29/100

Termination Rate

6.7%

2 terminated out of 30 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

37%

11 trials in Phase 3/4

Results Transparency

50%

4 of 8 completed with results

Key Signals

4 with results80% success

Data Visualizations

Phase Distribution

22Total
Not Applicable (9)
P 2 (2)
P 3 (5)
P 4 (6)

Trial Status

Completed8
Recruiting7
Not Yet Recruiting4
Active Not Recruiting4
Unknown3
Enrolling By Invitation2

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (30)

Showing 20 of 20 trials
NCT07303777Phase 2Recruiting

Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis

NCT05858879Not ApplicableCompletedPrimary

Notification of Incidental Coronary Artery Calcium in Patients With Atherosclerotic Cardiovascular Disease (NOTIFY-ASCVD)

NCT07491978Not Yet Recruiting

Development and Multicenter Validation of an AI-Based Remote Photoplethysmography (rPPG) Facial Scan for Multimodal Health Assessment

NCT07522645Not ApplicableNot Yet RecruitingPrimary

Adherence to Dyslipidemia Therapy: Harnessing Evidence From Randomized Evaluations in AtheroSclerotic CardioVascular Disease

NCT06691217Phase 2Recruiting

Effects of IL-1 Beta Inhibition on Vascular Inflammation in TET2 Clonal Hematopoiesis

NCT05390892Phase 4Recruiting

PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes

NCT07117695Not ApplicableNot Yet RecruitingPrimary

Duke Cardiometabolic Prevention Clinic's Impact on High-risk Cardiovascular Patients With Uncontrolled Risk Factors

NCT07417618Active Not Recruiting

INcreTin-based thERapies for Cardiovascular Event PrevenTion in Patients With and Without ASCVD (INTERCEPT-ASCVD)

NCT06960655Not ApplicableEnrolling By Invitation

Improving Lipid Optimization Quality and Treatment Options in ASCVD

NCT05088759Not ApplicableActive Not Recruiting

Randomized Controlled Trial of Alert-Based Computerized Decision Support for Optimizing Low-Density Lipoprotein Management

NCT05579626Phase 4Enrolling By Invitation

Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus (PROVE-DM)

NCT07270887RecruitingPrimary

The Long-term Effect of Remote Ischemic Conditioning on Main Organs in ASVCD Patients With Very High Risks

NCT06005597Phase 3Completed

Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies

NCT05611307Terminated

Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors

NCT06551701Active Not RecruitingPrimary

ACHIEVE Pilot Statins for Vascular Protection

NCT06471036Not ApplicableRecruitingPrimary

Test 2 Treat: Can we Improve the Testing and Treatment of High Cholesterol in Patients Who Have Been Hospitalized for a Cardiac Event by Providing Education to Doctors and Patients?

NCT06404515Not ApplicableCompletedPrimary

Telehealth Group Counseling and Preventive Care for Women

NCT06767774Phase 4RecruitingPrimary

Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus

NCT06568471Phase 3Recruiting

A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia

NCT06641661Not Yet Recruiting

NPC1L1 Gene Polymorphism and the Efficacy and Safety of Hybutimibe

Scroll to load more

Research Network

Activity Timeline